Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · IEX Real-Time Price · USD
1.750
+0.050 (2.94%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Xeris Biopharma Holdings Market Cap

Xeris Biopharma Holdings has a market cap or net worth of $259.44 million as of April 26, 2024. Its market cap has decreased by -13.32% in one year.

Market Cap
259.44M
Enterprise Value
416.18M
1-Year Change
-13.32%
Ranking
Category
Stock Price
$1.75

Market Cap Chart

Since June 21, 2018, Xeris Biopharma Holdings's market cap has decreased from $384.90M to $259.44M, a decrease of -32.59%. That is a compound annual growth rate of -6.52%.

History

DateMarket Cap% Change
Apr 26, 2024245.80M2.93%
Apr 25, 2024238.80M-3.40%
Apr 24, 2024247.20M-1.12%
Apr 23, 2024250.00M-
Apr 22, 2024250.00M2.29%
Apr 19, 2024244.40M-1.13%
Apr 18, 2024247.20M-1.12%
Apr 17, 2024250.00M-1.11%
Apr 16, 2024252.80M-2.69%
Apr 15, 2024259.80M-3.17%
Apr 12, 2024268.30M-5.89%
Apr 11, 2024285.10M2.52%
Apr 10, 2024278.10M-1.97%
Apr 9, 2024283.70M-
Apr 8, 2024283.70M-0.98%
Apr 5, 2024286.50M-0.49%
Apr 4, 2024287.90M-1.44%
Apr 3, 2024292.10M-0.48%
Apr 2, 2024293.50M-2.36%
Apr 1, 2024300.60M-3.16%
Mar 28, 2024310.40M8.34%
Mar 27, 2024286.50M-0.49%
Mar 26, 2024287.90M-2.87%
Mar 25, 2024296.40M0.47%
Mar 22, 2024295.00M-1.40%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Cybin 260.88M
Sight Sciences 260.16M
Invivyd 259.31M
ESSA Pharma 256.36M
ChromaDex 256.11M
Pyxis Oncology 255.21M
Bioventus 250.99M
Fennec Pharmaceuticals 250.95M
Market Cap Rankings